Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Leave a Reply

Your email address will not be published. Required fields are marked *

CONTACT US

Singapore

Kenda Singapore Pte Ltd
67 Loyang Way
Singapore 508757
Reg. No: 197801740K

Tel: (65) 6543-1183

Fax: (65) 6543-1182

General Sales Inquiries

KendaSing@kenda.net

Technical Support

TechSupport@Kenda.net

Indonesia

Kenda Indonesia JI Professor, Dr. Latumeten, Kompleks Grogol Permai Blok A, No. 24, Jakarta 11460, Indonesia

Email: KenIndo@kenda.net

Thailand

Kenda Technologies (Thailand) Ltd, Level 8, Zueling House, 1 Silom Road, Bangkok 10500, Thailand

Email: KenThai@kenda.net

Malaysia

Ken-Med Sdn Bhd, 568-10-44 Kompleks Mutiara, 3-1/2 Miles Jalan Ipoh, 51200 Kuala Lumpur, Malaysia

Email: KenMal@kenda.net

Philippines

Kenda Technologies Pte Ltd, 67 Loyang Way, Singapore 508757

Email: KenPhil@kenda.net

Request a Quote!
Get In Touch